1 Meningioma Drug Market Overview 1.1 Meningioma Drug Product Scope 1.2 Meningioma Drug Segment by Type 1.2.1 Global Meningioma Drug Sales by Type (2016 & 2021 & 2027) 1.2.2 Abemaciclib 1.2.3 Afatinib Dimaleate 1.2.4 AR-42 1.2.5 Avelumab 1.2.6 Others 1.3 Meningioma Drug Segment by Application 1.3.1 Global Meningioma Drug Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Meningioma Drug Market Estimates and Forecasts (2016-2027) 1.4.1 Global Meningioma Drug Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Meningioma Drug Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Meningioma Drug Price Trends (2016-2027) 2 Meningioma Drug Estimates and Forecasts by Region 2.1 Global Meningioma Drug Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Meningioma Drug Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Meningioma Drug Sales Market Share by Region (2016-2021) 2.2.2 Global Meningioma Drug Revenue Market Share by Region (2016-2021) 2.3 Global Meningioma Drug Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Meningioma Drug Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Meningioma Drug Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Meningioma Drug Estimates and Projections (2016-2027) 2.4.2 Europe Meningioma Drug Estimates and Projections (2016-2027) 2.4.3 China Meningioma Drug Estimates and Projections (2016-2027) 2.4.4 Japan Meningioma Drug Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Meningioma Drug Estimates and Projections (2016-2027) 2.4.6 India Meningioma Drug Estimates and Projections (2016-2027) 3 Global Meningioma Drug Competition Landscape by Players 3.1 Global Top Meningioma Drug Players by Sales (2016-2021) 3.2 Global Top Meningioma Drug Players by Revenue (2016-2021) 3.3 Global Meningioma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningioma Drug as of 2020) 3.4 Global Meningioma Drug Average Price by Company (2016-2021) 3.5 Manufacturers Meningioma Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Meningioma Drug Market Size by Type 4.1 Global Meningioma Drug Historic Market Review by Type (2016-2021) 4.1.1 Global Meningioma Drug Sales Market Share by Type (2016-2021) 4.1.2 Global Meningioma Drug Revenue Market Share by Type (2016-2021) 4.1.3 Global Meningioma Drug Price by Type (2016-2021) 4.2 Global Meningioma Drug Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Meningioma Drug Sales Forecast by Type (2022-2027) 4.2.2 Global Meningioma Drug Revenue Forecast by Type (2022-2027) 4.2.3 Global Meningioma Drug Price Forecast by Type (2022-2027) 5 Global Meningioma Drug Market Size by Application 5.1 Global Meningioma Drug Historic Market Review by Application (2016-2021) 5.1.1 Global Meningioma Drug Sales Market Share by Application (2016-2021) 5.1.2 Global Meningioma Drug Revenue Market Share by Application (2016-2021) 5.1.3 Global Meningioma Drug Price by Application (2016-2021) 5.2 Global Meningioma Drug Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Meningioma Drug Sales Forecast by Application (2022-2027) 5.2.2 Global Meningioma Drug Revenue Forecast by Application (2022-2027) 5.2.3 Global Meningioma Drug Price Forecast by Application (2022-2027) 6 North America Meningioma Drug Market Facts & Figures 6.1 North America Meningioma Drug Sales by Company 6.1.1 North America Meningioma Drug Sales by Company (2016-2021) 6.1.2 North America Meningioma Drug Revenue by Company (2016-2021) 6.2 North America Meningioma Drug Sales Breakdown by Type 6.2.1 North America Meningioma Drug Sales Breakdown by Type (2016-2021) 6.2.2 North America Meningioma Drug Sales Breakdown by Type (2022-2027) 6.3 North America Meningioma Drug Sales Breakdown by Application 6.3.1 North America Meningioma Drug Sales Breakdown by Application (2016-2021) 6.3.2 North America Meningioma Drug Sales Breakdown by Application (2022-2027) 7 Europe Meningioma Drug Market Facts & Figures 7.1 Europe Meningioma Drug Sales by Company 7.1.1 Europe Meningioma Drug Sales by Company (2016-2021) 7.1.2 Europe Meningioma Drug Revenue by Company (2016-2021) 7.2 Europe Meningioma Drug Sales Breakdown by Type 7.2.1 Europe Meningioma Drug Sales Breakdown by Type (2016-2021) 7.2.2 Europe Meningioma Drug Sales Breakdown by Type (2022-2027) 7.3 Europe Meningioma Drug Sales Breakdown by Application 7.3.1 Europe 126 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 126 Sales Breakdown by Application (2022-2027) 8 China Meningioma Drug Market Facts & Figures 8.1 China Meningioma Drug Sales by Company 8.1.1 China Meningioma Drug Sales by Company (2016-2021) 8.1.2 China Meningioma Drug Revenue by Company (2016-2021) 8.2 China Meningioma Drug Sales Breakdown by Type 8.2.1 China Meningioma Drug Sales Breakdown by Type (2016-2021) 8.2.2 China Meningioma Drug Sales Breakdown by Type (2022-2027) 8.3 China Meningioma Drug Sales Breakdown by Application 8.3.1 China 152 Sales Breakdown by Application (2016-2021) 8.3.2 China 152 Sales Breakdown by Application (2022-2027) 9 Japan Meningioma Drug Market Facts & Figures 9.1 Japan Meningioma Drug Sales by Company 9.1.1 Japan Meningioma Drug Sales by Company (2016-2021) 9.1.2 Japan Meningioma Drug Revenue by Company (2016-2021) 9.2 Japan Meningioma Drug Sales Breakdown by Type 9.2.1 Japan Meningioma Drug Sales Breakdown by Type (2016-2021) 9.2.2 Japan Meningioma Drug Sales Breakdown by Type (2022-2027) 9.3 Japan Meningioma Drug Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Meningioma Drug Market Facts & Figures 10.1 Southeast Asia Meningioma Drug Sales by Company 10.1.1 Southeast Asia Meningioma Drug Sales by Company (2016-2021) 10.1.2 Southeast Asia Meningioma Drug Revenue by Company (2016-2021) 10.2 Southeast Asia Meningioma Drug Sales Breakdown by Type 10.2.1 Southeast Asia Meningioma Drug Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Meningioma Drug Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Meningioma Drug Sales Breakdown by Application 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027) 11 India Meningioma Drug Market Facts & Figures 11.1 India Meningioma Drug Sales by Company 11.1.1 India Meningioma Drug Sales by Company (2016-2021) 11.1.2 India Meningioma Drug Revenue by Company (2016-2021) 11.2 India Meningioma Drug Sales Breakdown by Type 11.2.1 India Meningioma Drug Sales Breakdown by Type (2016-2021) 11.2.2 India Meningioma Drug Sales Breakdown by Type (2022-2027) 11.3 India Meningioma Drug Sales Breakdown by Application 11.3.1 India Meningioma Drug Sales Breakdown by Application (2016-2021) 11.3.2 India Meningioma Drug Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Meningioma Drug Business 12.1 Arno Therapeutics Inc 12.1.1 Arno Therapeutics Inc Corporation Information 12.1.2 Arno Therapeutics Inc Business Overview 12.1.3 Arno Therapeutics Inc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Arno Therapeutics Inc Meningioma Drug Products Offered 12.1.5 Arno Therapeutics Inc Recent Development 12.2 AstraZeneca Plc 12.2.1 AstraZeneca Plc Corporation Information 12.2.2 AstraZeneca Plc Business Overview 12.2.3 AstraZeneca Plc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.2.4 AstraZeneca Plc Meningioma Drug Products Offered 12.2.5 AstraZeneca Plc Recent Development 12.3 Boehringer Ingelheim GmbH 12.3.1 Boehringer Ingelheim GmbH Corporation Information 12.3.2 Boehringer Ingelheim GmbH Business Overview 12.3.3 Boehringer Ingelheim GmbH Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Boehringer Ingelheim GmbH Meningioma Drug Products Offered 12.3.5 Boehringer Ingelheim GmbH Recent Development 12.4 Eli Lilly and Co 12.4.1 Eli Lilly and Co Corporation Information 12.4.2 Eli Lilly and Co Business Overview 12.4.3 Eli Lilly and Co Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Eli Lilly and Co Meningioma Drug Products Offered 12.4.5 Eli Lilly and Co Recent Development 12.5 Genentech Inc 12.5.1 Genentech Inc Corporation Information 12.5.2 Genentech Inc Business Overview 12.5.3 Genentech Inc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Genentech Inc Meningioma Drug Products Offered 12.5.5 Genentech Inc Recent Development 12.6 GlaxoSmithKline Plc 12.6.1 GlaxoSmithKline Plc Corporation Information 12.6.2 GlaxoSmithKline Plc Business Overview 12.6.3 GlaxoSmithKline Plc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.6.4 GlaxoSmithKline Plc Meningioma Drug Products Offered 12.6.5 GlaxoSmithKline Plc Recent Development 12.7 Merck & Co Inc 12.7.1 Merck & Co Inc Corporation Information 12.7.2 Merck & Co Inc Business Overview 12.7.3 Merck & Co Inc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Merck & Co Inc Meningioma Drug Products Offered 12.7.5 Merck & Co Inc Recent Development 12.8 Merck KGaA 12.8.1 Merck KGaA Corporation Information 12.8.2 Merck KGaA Business Overview 12.8.3 Merck KGaA Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Merck KGaA Meningioma Drug Products Offered 12.8.5 Merck KGaA Recent Development 12.9 Novartis AG 12.9.1 Novartis AG Corporation Information 12.9.2 Novartis AG Business Overview 12.9.3 Novartis AG Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Novartis AG Meningioma Drug Products Offered 12.9.5 Novartis AG Recent Development 12.10 Ono Pharmaceutical Co Ltd 12.10.1 Ono Pharmaceutical Co Ltd Corporation Information 12.10.2 Ono Pharmaceutical Co Ltd Business Overview 12.10.3 Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Ono Pharmaceutical Co Ltd Meningioma Drug Products Offered 12.10.5 Ono Pharmaceutical Co Ltd Recent Development 12.11 Pharma Mar SA 12.11.1 Pharma Mar SA Corporation Information 12.11.2 Pharma Mar SA Business Overview 12.11.3 Pharma Mar SA Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Pharma Mar SA Meningioma Drug Products Offered 12.11.5 Pharma Mar SA Recent Development 12.12 Progenics Pharmaceuticals Inc 12.12.1 Progenics Pharmaceuticals Inc Corporation Information 12.12.2 Progenics Pharmaceuticals Inc Business Overview 12.12.3 Progenics Pharmaceuticals Inc Meningioma Drug Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Progenics Pharmaceuticals Inc Meningioma Drug Products Offered 12.12.5 Progenics Pharmaceuticals Inc Recent Development 13 Meningioma Drug Manufacturing Cost Analysis 13.1 Meningioma Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Meningioma Drug 13.4 Meningioma Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Meningioma Drug Distributors List 14.3 Meningioma Drug Customers 15 Market Dynamics 15.1 Meningioma Drug Market Trends 15.2 Meningioma Drug Drivers 15.3 Meningioma Drug Market Challenges 15.4 Meningioma Drug Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Meningioma Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Meningioma Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Meningioma Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Meningioma Drug Sales (K Pcs) by Region (2016-2021) Table 5. Global Meningioma Drug Sales Market Share by Region (2016-2021) Table 6. Global Meningioma Drug Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Meningioma Drug Revenue Share by Region (2016-2021) Table 8. Global Meningioma Drug Sales (K Pcs) Forecast by Region (2022-2027) Table 9. Global Meningioma Drug Sales Market Share Forecast by Region (2022-2027) Table 10. Global Meningioma Drug Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Meningioma Drug Revenue Share Forecast by Region (2022-2027) Table 12. Global Meningioma Drug Sales (K Pcs) of Key Companies (2016-2021) Table 13. Global Meningioma Drug Sales Share by Company (2016-2021) Table 14. Global Meningioma Drug Revenue (US$ Million) by Company (2016-2021) Table 15. Global Meningioma Drug Revenue Share by Company (2016-2021) Table 16. Global Meningioma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningioma Drug as of 2020) Table 17. Global Meningioma Drug Average Price (USD/Pcs) of Key Company (2016-2021) Table 18. Manufacturers Meningioma Drug Manufacturing Sites and Area Served Table 19. Manufacturers Meningioma Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Meningioma Drug Sales (K Pcs) by Type (2016-2021) Table 22. Global Meningioma Drug Sales Share by Type (2016-2021) Table 23. Global Meningioma Drug Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Meningioma Drug Price (USD/Pcs) by Type (2016-2021) Table 25. Global Meningioma Drug Sales Share by Type (2022-2027) Table 26. Global Meningioma Drug Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Meningioma Drug Revenue Share by Type (2022-2027) Table 28. Global Meningioma Drug Price (USD/Pcs) by Type (2022-2027) Table 29. Global Meningioma Drug Sales (K Pcs) by Application (2016-2021) Table 30. Global Meningioma Drug Sales Share by Application (2016-2021) Table 31. Global Meningioma Drug Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Meningioma Drug Price (USD/Pcs) by Application (2016-2021) Table 33. Global Meningioma Drug Sales (K Pcs) by Application (2022-2027) Table 34. Global Meningioma Drug Sales Share by Application (2022-2027) Table 35. Global Meningioma Drug Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Meningioma Drug Revenue Share by Application (2022-2027) Table 37. Global Meningioma Drug Price (USD/Pcs) by Application (2022-2027) Table 38. North America Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 39. North America Meningioma Drug Sales Market Share by Company (2016-2021) Table 40. North America Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Meningioma Drug Revenue Market Share by Company (2016-2021) Table 42. North America Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 43. North America Meningioma Drug Sales Market Share by Type (2016-2021) Table 44. North America Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 45. North America Meningioma Drug Sales Market Share by Type (2022-2027) Table 46. North America Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 47. North America Meningioma Drug Sales Market Share by Application (2016-2021) Table 48. North America Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 49. North America Meningioma Drug Sales Market Share by Application (2022-2027) Table 50. Europe Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 51. Europe Meningioma Drug Sales Market Share by Company (2016-2021) Table 52. Europe Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Meningioma Drug Revenue Market Share by Company (2016-2021) Table 54. Europe Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 55. Europe Meningioma Drug Sales Market Share by Type (2016-2021) Table 56. Europe Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 57. Europe Meningioma Drug Sales Market Share by Type (2022-2027) Table 58. Europe Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 59. Europe Meningioma Drug Sales Market Share by Application (2016-2021) Table 60. Europe Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 61. Europe Meningioma Drug Sales Market Share by Application (2022-2027) Table 62. China Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 63. China Meningioma Drug Sales Market Share by Company (2016-2021) Table 64. China Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 65. China Meningioma Drug Revenue Market Share by Company (2016-2021) Table 66. China Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 67. China Meningioma Drug Sales Market Share by Type (2016-2021) Table 68. China Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 69. China Meningioma Drug Sales Market Share by Type (2022-2027) Table 70. China Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 71. China Meningioma Drug Sales Market Share by Application (2016-2021) Table 72. China Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 73. China Meningioma Drug Sales Market Share by Application (2022-2027) Table 74. Japan Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 75. Japan Meningioma Drug Sales Market Share by Company (2016-2021) Table 76. Japan Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Meningioma Drug Revenue Market Share by Company (2016-2021) Table 78. Japan Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 79. Japan Meningioma Drug Sales Market Share by Type (2016-2021) Table 80. Japan Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 81. Japan Meningioma Drug Sales Market Share by Type (2022-2027) Table 82. Japan Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 83. Japan Meningioma Drug Sales Market Share by Application (2016-2021) Table 84. Japan Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 85. Japan Meningioma Drug Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 87. Southeast Asia Meningioma Drug Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Meningioma Drug Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 91. Southeast Asia Meningioma Drug Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 93. Southeast Asia Meningioma Drug Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 95. Southeast Asia Meningioma Drug Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 97. Southeast Asia Meningioma Drug Sales Market Share by Application (2022-2027) Table 98. India Meningioma Drug Sales (K Pcs) by Company (2016-2021) Table 99. India Meningioma Drug Sales Market Share by Company (2016-2021) Table 100. India Meningioma Drug Revenue by Company (2016-2021) & (US$ Million) Table 101. India Meningioma Drug Revenue Market Share by Company (2016-2021) Table 102. India Meningioma Drug Sales by Type (2016-2021) & (K Pcs) Table 103. India Meningioma Drug Sales Market Share by Type (2016-2021) Table 104. India Meningioma Drug Sales by Type (2022-2027) & (K Pcs) Table 105. India Meningioma Drug Sales Market Share by Type (2022-2027) Table 106. India Meningioma Drug Sales by Application (2016-2021) & (K Pcs) Table 107. India Meningioma Drug Sales Market Share by Application (2016-2021) Table 108. India Meningioma Drug Sales by Application (2022-2027) & (K Pcs) Table 109. India Meningioma Drug Sales Market Share by Application (2022-2027) Table 110. Arno Therapeutics Inc Corporation Information Table 111. Arno Therapeutics Inc Description and Business Overview Table 112. Arno Therapeutics Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. Arno Therapeutics Inc Meningioma Drug Product Table 114. Arno Therapeutics Inc Recent Development Table 115. AstraZeneca Plc Corporation Information Table 116. AstraZeneca Plc Description and Business Overview Table 117. AstraZeneca Plc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. AstraZeneca Plc Meningioma Drug Product Table 119. AstraZeneca Plc Recent Development Table 120. Boehringer Ingelheim GmbH Corporation Information Table 121. Boehringer Ingelheim GmbH Description and Business Overview Table 122. Boehringer Ingelheim GmbH Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Boehringer Ingelheim GmbH Meningioma Drug Product Table 124. Boehringer Ingelheim GmbH Recent Development Table 125. Eli Lilly and Co Corporation Information Table 126. Eli Lilly and Co Description and Business Overview Table 127. Eli Lilly and Co Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Eli Lilly and Co Meningioma Drug Product Table 129. Eli Lilly and Co Recent Development Table 130. Genentech Inc Corporation Information Table 131. Genentech Inc Description and Business Overview Table 132. Genentech Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. Genentech Inc Meningioma Drug Product Table 134. Genentech Inc Recent Development Table 135. GlaxoSmithKline Plc Corporation Information Table 136. GlaxoSmithKline Plc Description and Business Overview Table 137. GlaxoSmithKline Plc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. GlaxoSmithKline Plc Meningioma Drug Product Table 139. GlaxoSmithKline Plc Recent Development Table 140. Merck & Co Inc Corporation Information Table 141. Merck & Co Inc Description and Business Overview Table 142. Merck & Co Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Merck & Co Inc Meningioma Drug Product Table 144. Merck & Co Inc Recent Development Table 145. Merck KGaA Corporation Information Table 146. Merck KGaA Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Merck KGaA Description and Business Overview Table 148. Merck KGaA Meningioma Drug Product Table 149. Merck KGaA Recent Development Table 150. Novartis AG Corporation Information Table 151. Novartis AG Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Novartis AG Description and Business Overview Table 153. Novartis AG Meningioma Drug Product Table 154. Novartis AG Recent Development Table 155. Ono Pharmaceutical Co Ltd Corporation Information Table 156. Ono Pharmaceutical Co Ltd Description and Business Overview Table 157. Ono Pharmaceutical Co Ltd Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Ono Pharmaceutical Co Ltd Meningioma Drug Product Table 159. Ono Pharmaceutical Co Ltd Recent Development Table 160. Pharma Mar SA Corporation Information Table 161. Pharma Mar SA Description and Business Overview Table 162. Pharma Mar SA Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. Pharma Mar SA Meningioma Drug Product Table 164. Pharma Mar SA Recent Development Table 165. Progenics Pharmaceuticals Inc Corporation Information Table 166. Progenics Pharmaceuticals Inc Description and Business Overview Table 167. Progenics Pharmaceuticals Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. Progenics Pharmaceuticals Inc Meningioma Drug Product Table 169. Progenics Pharmaceuticals Inc Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Meningioma Drug Distributors List Table 173. Meningioma Drug Customers List Table 174. Meningioma Drug Market Trends Table 175. Meningioma Drug Market Drivers Table 176. Meningioma Drug Market Challenges Table 177. Meningioma Drug Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Meningioma Drug Product Picture Figure 2. Global Meningioma Drug Sales Market Share by Type in 2021 & 2027 Figure 3. Abemaciclib Product Picture Figure 4. Afatinib Dimaleate Product Picture Figure 5. AR-42 Product Picture Figure 6. Avelumab Product Picture Figure 7. Others Product Picture Figure 8. Global Meningioma Drug Sales Market Share by Application in 2021 & 2027 Figure 9. Hospital Examples Figure 10. Clinic Examples Figure 11. Others Examples Figure 12. Global Meningioma Drug Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Meningioma Drug Sales Growth Rate (2016-2027) & (US$ Million) Figure 14. Global Meningioma Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 15. Global Meningioma Drug Price Trends Growth Rate (2016-2027) (USD/Pcs) Figure 16. Global Meningioma Drug Revenue Market Share by Region: 2016 VS 2021 Figure 17. Global Meningioma Drug Revenue Market Share by Region: 2021 VS 2027 Figure 18. North America Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 19. North America Meningioma Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 20. Europe Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Europe Meningioma Drug Sales (Million USD) Growth Rate (2016-2027) Figure 22. China Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 23. China Meningioma Drug Sales (Million USD) and Growth Rate (2016-2027) Figure 24. Japan Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Japan Meningioma Drug Sales (Million USD) Growth Rate (2016-2027) Figure 26. Southeast Asia Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 27. Southeast Asia Meningioma Drug Sales (Million USD) Growth Rate (2016-2027) Figure 28. India Meningioma Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 29. India Meningioma Drug Sales (Million USD) Growth Rate (2016-2027) Figure 30. Global 5 Largest Meningioma Drug Players Market Share by Revenue in Meningioma Drug: 2016 & 2020 Figure 31. Meningioma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 32. Global Meningioma Drug Revenue Share by Type (2016-2021) Figure 33. Global Meningioma Drug Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Global Meningioma Drug Revenue Share by Application (2016-2021) Figure 35. Global Meningioma Drug Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Meningioma Drug Sales Market Share by Type in 2020 Figure 37. North America Meningioma Drug Sales Market Share by Application in 2020 Figure 38. Europe Meningioma Drug Sales Market Share by Type in 2020 Figure 39. Europe Meningioma Drug Sales Market Share by Application in 2020 Figure 40. China Meningioma Drug Sales Market Share by Type in 2020 Figure 41. China Meningioma Drug Sales Market Share by Application in 2020 Figure 42. Japan Meningioma Drug Sales Market Share by Type in 2020 Figure 43. Japan Meningioma Drug Sales Market Share by Application in 2020 Figure 44. Southeast Asia Meningioma Drug Sales Market Share by Type in 2020 Figure 45. Southeast Asia Meningioma Drug Sales Market Share by Application in 2020 Figure 46. India Meningioma Drug Sales Market Share by Type in 2020 Figure 47. India Meningioma Drug Sales Market Share by Application in 2020 Figure 48. Key Raw Materials Price Trend Figure 49. Manufacturing Cost Structure of Meningioma Drug Figure 50. Manufacturing Process Analysis of Meningioma Drug Figure 51. Meningioma Drug Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Arno Therapeutics Inc AstraZeneca Plc Boehringer Ingelheim GmbH Eli Lilly and Co Genentech Inc GlaxoSmithKline Plc Merck & Co Inc Merck KGaA Novartis AG Ono Pharmaceutical Co Ltd Pharma Mar SA Progenics Pharmaceuticals Inc